Skip to main content

Advertisement

SpringerLink
Log in

Nutrients, vitamins, probiotics and herbal products: an update of their role in urolithogenesis

  • Invited Review
  • Published:
Urolithiasis Aims and scope Submit manuscript

A Correction to this article was published on 28 April 2020

This article has been updated

Abstract

Nutrients, vitamins, probiotics, and herbal products may be risk factors, or alternately, protect against the formation of urinary stones. The purpose of this review was to update knowledge of the role of nutraceuticals in renal stone formation. A systematic search of the relevant literature published in PubMed in the last ten years was conducted and a narrative review of the data from the included studies was done. Search screened 513 studies that were reduced to 34 after evaluation by title and abstract; other 38 studies were retrieved by references of the selected studies. Beverages high fluid intake confirmed protective effect; orange juice protective effect; apple or grapefruit juice not confirmed as risk factors; sugar-sweetened soda and punch increased risk of stone formation. Energy intake: very high energy intake increased risk factor for women (especially after menopause); dietary acid load increased risk at equal levels of energy intake. Macronutrients confirmed increased risk of high protein intake. Calcium and Oxalate: calcium intake protective effect; oxalate intake only modest increase of risk in men and older women. Metal cations zinc and iron intake no clear impact on the risk of stone formation, dietary copper increased risk; manganese intake reduced risk of stone formation. Fruits and Vegetables decreased risk. Vitamins B6 intake not associated to risk of stone formation; vitamin C intake increased risk in men; vitamin D or supplemental vitamin D intake not associated to increased risk in men and younger women, suggestion of a higher risk in older women; Probiotics Gut colonization with Oxalobacter formigenes associated to lower risk of stone formation, effect of oxalate-degraders probiotics on urinary oxalate equivocal. Herbal products efficacy of some herbal products demonstrated in some trials, more investigations needed to confirm their efficacy and safety.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Change history

  • 28 April 2020

    The original version of this article unfortunately contained a mistake.

References

  1. Curhan GC, Curhan SG (1994) Dietary factors and kidney stone formation. Compr Ther 20:485–489

    CAS  PubMed  Google Scholar 

  2. Taylor EN, Curhan GC (2006) Diet and fluid prescription in stone disease. Kidney Int 70:835–839

    CAS  PubMed  Google Scholar 

  3. Curhan GC, Willett WC, Rimm EB et al (1993) A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328:833–838

    CAS  PubMed  Google Scholar 

  4. Curhan G, Willett W, Speizer F et al (1997) Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 126:497–504

    CAS  PubMed  Google Scholar 

  5. Curhan GC, Willett WC, Knight EL et al (2004) Dietary factors and the risk of incident kidney stones in younger women (Nurses’ Health Study II). Arch Intern Med 164:885–891

    PubMed  Google Scholar 

  6. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155:839–844

    CAS  PubMed  Google Scholar 

  7. Curhan GC, Willett WC, Rimm EB et al (1996) Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 143:240–247

    CAS  PubMed  Google Scholar 

  8. Curhan GC, Willett WC, Speizer FE et al (1998) Beverage use and risk for kidney stones in women. Ann Intern Med 128:534–540

    CAS  PubMed  Google Scholar 

  9. Shuster J, Jenkins A, Logan C, Barnett T, Riehle R, Zackson D, Wolfe H, Dale R, Daley M, Malik I et al (1992) Soft drink consumption and urinary stone recurrence: a randomized prevention trial. J Clin Epidemiol 45:911–916

    CAS  PubMed  Google Scholar 

  10. Ferraro PM, Taylor EN, Gambaro G, Curhan GC (2013) Soda and other beverages and the risk of kidney stones. Clin J Am Soc Nephrol 8:1389–1395

    PubMed  PubMed Central  Google Scholar 

  11. Wabner CL, Pak CY (1993) Effect of orange juice consumption on urinary stone risk factors. J Urol 149:1405–1408

    CAS  PubMed  Google Scholar 

  12. Odvina CV (2006) Comparative value of orange juice versus lemonade in reducing stone-forming risk. Clin J Am Soc Nephrol 1:1269–1274

    CAS  PubMed  Google Scholar 

  13. Shu X, Cai H, Xiang YB, Li H, Lipworth L, Miller NL, Zheng W, Shu XO, Hsi RS (2019) Green tea intake and risk of incident kidney stones: prospective cohort studies in middle-aged and elderly Chinese individuals. Int J Urol 26:241–246

    CAS  PubMed  Google Scholar 

  14. Chen HY, Wu JS, Chang YF, Sun ZJ, Chang CJ, Lu FH, Yang YC (2019) Increased amount and duration of tea consumption may be associated with decreased risk of renal stone disease. World J Urol 37:379–384

    PubMed  Google Scholar 

  15. Curhan GC, Willett WC, Rimm EB, Speizer FE, Stampfer MJ (1998) Body size and risk of kidney stones. J Am Soc Nephrol 9:1645–1652

    CAS  PubMed  Google Scholar 

  16. West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H (2008) Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–94. Am J Kidney Dis 51:741–747

    PubMed  Google Scholar 

  17. Rendina D, Mossetti G, De Filippo G, Benvenuto D, Vivona CL, Imbroinise A, Zampa G, Ricchio S, Strazzullo P (2009) Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and abdominal obesity. Nephrol Dial Transplant 24:900–906

    PubMed  Google Scholar 

  18. Jeong IG, Kang T, Bang JK, Park J, Kim W, Hwang SS (2011) Association between metabolic syndrome and the presence of kidney stones in a screened population. Am J Kidney Dis 58:383–388

    PubMed  Google Scholar 

  19. Rendina D, De Filippo G, D'Elia L, Strazzullo P (2014) Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence. J Nephrol 27:371–376

    CAS  PubMed  Google Scholar 

  20. Al Zahrani H, Norman RW, Thompson C, Weerasinghe S (2000) The dietary habits of idiopathic calcium stone-formers and normal control subjects. BJU Int 85:616–620

    CAS  PubMed  Google Scholar 

  21. Aune D, Mahamat-Saleh Y, Norat T, Riboli E (2018) Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol 33:1033–1047

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Sorensen MD, Chi T, Shara NM, Wang H, Hsi RS, Orchard T, Kahn AJ, Jackson RD, Miller J, Reiner AP, Stoller ML (2014) Activity, energy intake, obesity, and the risk of incident kidney stones in postmenopausal women: a report from the Women’s Health Initiative. J Am Soc Nephrol 25:362–369

    PubMed  Google Scholar 

  23. Shu X, Cai H, Xiang YB, Li H, Lipworth L, Miller NL, Zheng W, Shu XO, Hsi RS (2017) Nephrolithiasis among middle aged and elderly urban Chinese: a report from prospective cohort studies in Shanghai. J Endourol 31:1327–1334

    PubMed  PubMed Central  Google Scholar 

  24. Oda E (2014) Overweight and high-sensitivity C-reactive protein are weakly associated with kidney stone formation in Japanese men. Int J Urol 21:1005–1011

    CAS  PubMed  Google Scholar 

  25. Yoshimura E, Sawada SS, Lee IM et al (2016) Body mass index and kidney stones: a cohort study of Japanese men. J Epidemiol 26:131–136

    PubMed  Google Scholar 

  26. Ferraro PM, Curhan GC, Sorensen MD, Gambaro G, Taylor EN (2015) Physical activity, energy intake and the risk of incident kidney stones. J Urol 193:864–868

    PubMed  Google Scholar 

  27. Trinchieri A, Maletta A, Lizzano R, Marchesotti F (2013) Potential renal acid load and the risk of renal stone formation in a case-control study. Eur J Clin Nutr 67:1077–1080

    CAS  PubMed  Google Scholar 

  28. Vezzoli G, Dogliotti E, Terranegra A, Arcidiacono T, Macrina L, Tavecchia M, Pivari F, Mingione A, Brasacchio C, Nouvenne A, Meschi T, Cusi D, Spotti D, Montanari E, Soldati L (2015) Dietary style and acid load in an Italian population of calcium kidney stone formers. Nutr Metab Cardiovasc Dis 25:588–593

    CAS  PubMed  Google Scholar 

  29. Ferraro PM, Mandel EI, Curhan GC, Gambaro G, Taylor EN (2016) Dietary protein and potassium, diet-dependent net acid load, and risk of incident kidney stones. Clin J Am Soc Nephrol 11:1834–1844

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Taylor EN, Fung TT, Curhan GC (2009) DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol 20:2253–2259

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Leone A, Fernández-Montero A, de la Fuente-Arrillaga C, Martínez-González MÁ, Bertoli S, Battezzati A, Bes-Rastrollo M (2017) Adherence to the Mediterranean dietary pattern and incidence of nephrolithiasis in the Seguimiento Universidad de Navarra follow-up (SUN) cohort. Am J Kidney Dis 70:778–786

    PubMed  Google Scholar 

  32. Siener R, Jansen B, Watzer B, Hesse A (2011) Effect of n-3 fatty acid supplementation on urinary risk factors for calcium oxalate stone formation. J Urol 185:719–724

    CAS  PubMed  Google Scholar 

  33. Yasui T, Suzuki S, Itoh Y, Tozawa K, Tokudome S, Kohri K (2008) Eicosapentaenoic acid has a preventive effect on the recurrence of nephrolithiasis. Urol Int 81:135–138

    CAS  PubMed  Google Scholar 

  34. Taylor EN, Stampfer MJ, Curhan GC (2005) Fatty acid intake and incident nephrolithiasis. Am J Kidney Dis 45:267–274

    CAS  PubMed  Google Scholar 

  35. Ferraro PM, Taylor EN, Gambaro G, Curhan GC (2017) Dietary and lifestyle risk factors associated with incident kidney stones in men and women. J Urol 198:858–863

    PubMed  PubMed Central  Google Scholar 

  36. Turney BW, Appleby PN, Reynard JM, Noble JG, Key TJ, Allen NE (2014) Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Epidemiol 29:363–369

    CAS  PubMed  Google Scholar 

  37. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346:77–84

    CAS  PubMed  Google Scholar 

  38. Taylor EN, Curhan GC (2007) Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol 18:2198–2204

    CAS  PubMed  Google Scholar 

  39. Taylor EN, Curhan GC (2013) Dietary calcium from dairy and nondairy sources, and risk of symptomatic kidney stones. J Urol 190:1255–1259

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Taylor EN, Stampfer MJ, Curhan GC (2004) Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol 15:3225–3232

    PubMed  Google Scholar 

  41. Tang J, McFann K, Chonchol M (2012) Dietary zinc intake and kidney stone formation: evaluation of NHANES III. Am J Nephrol 36:549–553

    PubMed  Google Scholar 

  42. Thomas LD, Elinder CG, Tiselius HG, Wolk A, Akesson A (2013) Dietary cadmium exposure and kidney stone incidence: a population-based prospective cohort study of men & women. Environ Int 59:148–151

    CAS  PubMed  Google Scholar 

  43. Ferraro PM, Bonello M, Frigo AC, D'Addessi A, Sturniolo A, Gambaro G (2011) Cadmium exposure and kidney stone formation in the general population—an analysis of the National Health and Nutrition Examination Survey III data. J Endourol 25:875–880

    PubMed  Google Scholar 

  44. Ferraro PM, Gambaro G, Curhan GC, Taylor EN (2018) Intake of trace metals and the risk of incident kidney stones. J Urol 199:1534–1539

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Taylor EN, Curhan GC (2008) Fructose consumption and the risk of kidney stones. Kidney Int 73:207–212

    CAS  PubMed  Google Scholar 

  46. Meschi T, Maggiore U, Fiaccadori E, Schianchi T, Bosi S, Adorni G, Ridolo E, Guerra A, Allegri F, Novarini A, Borghi L (2004) The effect of fruits and vegetables on urinary stone risk factors. Kidney Int 66:2402–2410

    CAS  PubMed  Google Scholar 

  47. Sorensen MD, Hsi RS, Chi T, Shara N, Wactawski-Wende J, Kahn AJ, Wang H, Hou L, Stoller ML, Women’s Health Initiative Writing Group (2014) (2014) Dietary intake of fiber, fruit and vegetables decreases the risk of incident kidney stones in women: a Women's Health Initiative report. J Urol 192:1694–1699

    PubMed  PubMed Central  Google Scholar 

  48. Ferraro PM, Curhan GC, Gambaro G, Taylor EN (2019) Antibiotic use and risk of incident kidney stones in female nurses. Am J Kidney Dis 74(6):736–741

    CAS  PubMed  Google Scholar 

  49. Curhan GC, Willett WC, Rimm EB et al (1996) A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men. J Urol 155:1847–1851

    CAS  PubMed  Google Scholar 

  50. Curhan GC, Willett WC, Speizer FE et al (1999) Intake of vitamins B6 and C and the risk of kidney stones in women. J Am Soc Nephrol 10:840–845

    CAS  PubMed  Google Scholar 

  51. Letavernier E, Daudon M (2018) Vitamin D, hypercalciuria and kidney stones. Nutrients 10:pii:E366

    Google Scholar 

  52. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D, Investigators WHI (2006) Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354:669–683

    CAS  PubMed  Google Scholar 

  53. Taylor EN, Stampfer MJ, Curhan GC (2004) Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol JASN 15:3225–3232

    PubMed  Google Scholar 

  54. Ferraro PM, Taylor EN, Gambaro G, Curhan GC (2018) Vitamin B6 intake and the risk of incident kidney stones. Urolithiasis 46:265–270

    CAS  PubMed  Google Scholar 

  55. Ferraro PM, Curhan GC, Gambaro G, Taylor EN (2016) Total, dietary, and supplemental vitamin C intake and risk of incident kidney stones. Am J Kidney Dis 67:400–407

    CAS  PubMed  Google Scholar 

  56. Lappe J, Watson P, Travers-Gustafson D, Recker R, Garland C, Gorham E, Baggerly K, McDonnell SL (2017) Effect of vitamin D and calcium supplementation on cancer incidence in older women: a randomized clinical trial. JAMA 317:1234–1243

    CAS  PubMed  Google Scholar 

  57. Wallace RB, Wactawski-Wende J, O'Sullivan MJ, Larson JC, Cochrane B, Gass M, Masaki K (2011) Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements. Am J Clin Nutr 94:270–277

    CAS  PubMed  PubMed Central  Google Scholar 

  58. Prentice RL, Pettinger MB, Jackson RD, Wactawski-Wende J, Lacroix AZ, Anderson GL, Chlebowski RT, Manson JE, Van Horn L, Vitolins MZ, Datta M, LeBlanc ES, Cauley JA, Rossouw JE (2013) Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos Int 24:567–580

    CAS  PubMed  Google Scholar 

  59. Malihi Z, Lawes CMM, Wu Z, Huang Y, Waayer D, Toop L, Khaw KT, Camargo CA, Scragg R (2019) Monthly high-dose vitamin D supplementation does not increase kidney stone risk or serum calcium: results from a randomized controlled trial. Am J Clin Nutr 109:1578–1587

    PubMed  Google Scholar 

  60. Avenell A, Mak JC, O'Connell D (2014) Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev (4):CD000227

  61. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C (2014) Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev (1):CD007470

  62. Kahwati LC, Weber RP, Pan H, Gourlay M, LeBlanc E, Coker-Schwimmer M, Viswanathan M (2018) Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: evidence report and systematic review for the US preventive services task force. JAMA 319:1600–1612

    PubMed  Google Scholar 

  63. Malihi Z, Wu Z, Stewart AW, Lawes CM, Scragg R (2016) Hypercalcemia, hypercalciuria, and kidney stones in long-term studies of vitamin D supplementation: a systematic review and meta-analysis. Am J Clin Nutr 104:1039–1051

    CAS  PubMed  Google Scholar 

  64. Ferraro PM, Taylor EN, Gambaro G, Curhan GC (2017) Vitamin D intake and the risk of incident kidney stones. J Urol 197:405–410

    CAS  PubMed  Google Scholar 

  65. Wei FF, Thijs L, Zhang ZY, Jacobs L, Yang WY, Salvi E, Citterio L, Cauwenberghs N, Kuznetsova T, Drummen NEA, Hara A, Manunta P, Li Y, Verhamme P, Allegaert K, Cusi D, Vermeer C, Staessen JA (2018) The risk of nephrolithiasis is causally related to inactive matrix Gla protein, a marker of vitamin K status: a Mendelian randomization study in a Flemish population. Nephrol Dial Transplant 33:514–522

    CAS  PubMed  Google Scholar 

  66. Thamilselvan S, Menon M (2005) Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status. BJU Int 96:117–126

    CAS  PubMed  Google Scholar 

  67. Sidhu H, Schmidt ME, Cornelius JG, Thamilselvan S, Khan SR, Hesse A, Peck AB (1999) Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 10(Suppl 14):S334–S340

    CAS  PubMed  Google Scholar 

  68. Sakhaee K (2014) Epidemiology and clinical pathophysiology of uric acid kidney stones. J Nephrol 27:241–245

    CAS  PubMed  PubMed Central  Google Scholar 

  69. Stern JM, Moazami S, Qiu Y, Kurland I, Chen Z, Agalliu I, Burk R, Davies KP (2016) Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers. Urolithiasis 44:399–407

    PubMed  Google Scholar 

  70. Mehta M, Goldfarb DS, Nazzal L (2016) The role of the microbiome in kidney stone formation. Int J Surg 36:607–612

    PubMed  PubMed Central  Google Scholar 

  71. Ticinesi A, Milani C, Guerra A, Allegri F, Lauretani F, Nouvenne A, Mancabelli L, Lugli GA, Turroni F, Duranti S, Mangifesta M, Viappiani A, Ferrario C, Dodi R, Dall'Asta M, Del Rio D, Ventura M, Meschi T (2018) Understanding the gut-kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers. Gut 67:2097–2106

    CAS  PubMed  Google Scholar 

  72. Liebman M, Al-Wahsh IA (2011) Probiotics and other key determinants of dietary oxalate absorption. Adv Nutr 2:254–260

    CAS  PubMed  PubMed Central  Google Scholar 

  73. Kumar R, Mukherjee M, Bhandari M, Kumar A, Sidhu H, Mittal RD (2002) Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India. Eur Urol 41:318–322

    CAS  PubMed  Google Scholar 

  74. Mittal RD, Kumar R, Mittal B, Prasad R, Bhandari M (2003) Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation. Med Princ Pract 12:208–213

    CAS  PubMed  Google Scholar 

  75. Kwak C, Kim HK, Kim EC, Choi MS, Kim HH (2003) Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Eur Urol 44:475–481

    CAS  PubMed  Google Scholar 

  76. Troxel SA, Sidhu H, Kaul P, Low RK (2003) Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol 17:173–176

    PubMed  Google Scholar 

  77. Siener R, Bangen U, Sidhu H, Hönow R, von Unruh G, Hesse A (2013) The role of Oxalobacter formigenes colonization in calcium oxalate stone disease. Kidney Int 83:1144–1149

    CAS  PubMed  Google Scholar 

  78. Kaufman DW, Kelly JP, Curhan GC, Anderson TE, Dretler SP, Preminger GM, Cave DR (2008) Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol 19:1197–1203

    CAS  PubMed  PubMed Central  Google Scholar 

  79. Siva S, Barrack ER, Reddy GP, Thamilselvan V, Thamilselvan S, Menon M, Bhandari M (2009) A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease. BJU Int 103:18–21

    PubMed  Google Scholar 

  80. Duncan SH, Richardson AJ, Kaul P, Holmes RP, Allison MJ, Stewart CS (2002) Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol 68:3841–3847

    CAS  PubMed  PubMed Central  Google Scholar 

  81. Hoppe B, Beck B, Gatter N (2006) Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Kidney Int 70:1305–1310

    CAS  PubMed  Google Scholar 

  82. Jairath A, Parekh N, Otano N, Mishra S, Ganpule A, Sabnis R, Desai M (2015) Oxalobacter formigenes: opening the door to probiotic therapy for the treatment of hyperoxaluria. Scand J Urol 49:334–337

    CAS  PubMed  Google Scholar 

  83. Milliner D, Hoppe B, Groothoff J (2018) A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria. Urolithiasis 46:313–323

    CAS  PubMed  Google Scholar 

  84. Hoppe B, Niaudet P, Salomon R, Harambat J, Hulton SA, Van't Hoff W, Moochhala SH, Deschênes G, Lindner E, Sjögren A, Cochat P (2017) A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria. Pediatr Nephrol 32:781–790

    PubMed  Google Scholar 

  85. Lieske JC, Goldfarb DS, De Simone C, Regnier C (2005) Use of a probiotic to decrease enteric hyperoxaluria. Kidney Int 68:1244–1249

    CAS  PubMed  Google Scholar 

  86. Goldfarb DS, Modersitzki F, Asplin JR (2007) A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria. Clin J Am Soc Nephrol 2:745–749

    PubMed  Google Scholar 

  87. Lieske JC, Tremaine WJ, De Simone C, O'Connor HM, Li X, Bergstralh EJ, Goldfarb DS (2010) Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation. Kidney Int 78:1178–1185

    CAS  PubMed  PubMed Central  Google Scholar 

  88. Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, Stefoni S, Pirovano F, Centi C, Ulisse S, Famularo G, De Simone C (2001) Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 60:1097–1105

    CAS  PubMed  Google Scholar 

  89. Suryavanshi MV, Bhute SS, Gune RP, Shouche YS (2018) Functional eubacteria species along with trans-domain gut inhabitants favour dysgenic diversity in oxalate stone disease. Sci Rep 8:16598

    PubMed  PubMed Central  Google Scholar 

  90. Miller AW, Choy D, Penniston KL, Lange D (2019) Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis. Kidney Int 96:180–188

    CAS  PubMed  PubMed Central  Google Scholar 

  91. Zampini A, Nguyen AH, Rose E, Monga M, Miller AW (2019) Defining dysbiosis in patients with urolithiasis. Sci Rep 9:5425

    PubMed  PubMed Central  Google Scholar 

  92. Peck AB, Canales BK, Nguyen CQ (2016) Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease? Urolithiasis 44:45–50

    CAS  PubMed  Google Scholar 

  93. Khan SR (2013) Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. J Urol 189:803–811

    CAS  PubMed  Google Scholar 

  94. Khan SR (2004) Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 8:75–88

    CAS  PubMed  Google Scholar 

  95. Khan SR (2014) Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis. Transl Androl Urol 3:256–276

    PubMed  PubMed Central  Google Scholar 

  96. Nirumand MC, Hajialyani M, Rahimi R, Farzaei MH, Zingue S, Nabavi SM, Bishayee A (2018) Dietary plants for the prevention and management of kidney stones: preclinical and clinical evidence and molecular mechanisms. Int J Mol Sci. 19:pii:E765

    Google Scholar 

  97. Cealan A, Coman RT, Simon V, Andras I, Telecan T, Coman I, Crisan N (2019) Evaluation of the efficacy of Phyllanthus niruri standardized extract combined with magnesium and vitamin B6 for the treatment of patients with uncomplicated nephrolithiasis. Med Pharm Rep 92:153–157

    PubMed  PubMed Central  Google Scholar 

  98. Premgamone A, Sriboonlue P, Disatapornjaroen W et al (2001) A long-term study on the efficacy of a herbal plant, Orthosiphon grandiflorus, and sodium potassium citrate in renal calculi treatment. Southeast Asian J Trop Med Public Health 32:654–660

    CAS  PubMed  Google Scholar 

  99. Singh RG, Behura SK, Kumar R (2010) Litholytic property of Kulattha (Dolichous biflorus) vs potassium citrate in renal calculus disease: a comparative study. J Assoc Physicians India 58:286–289

    PubMed  Google Scholar 

  100. Singh I, Bishnoi I, Agarwal V, Bhatt S (2011) Prospective randomized clinical trial comparing phytotherapy with potassium citrate in management of minimal burden (≤ 8 mm) nephrolithiasis. Urol Ann 3:75–81

    CAS  PubMed  PubMed Central  Google Scholar 

  101. Singh RG, Singh TB, Kumar R et al (2012) A comparative pilot study of litholytic properties of Celosia argental (Sitivaraka) versus potassium citrate in renal calculus disease. J Altern Complement Med 18:427–428

    PubMed  Google Scholar 

  102. Brardi S, Imperiali P, Cevenini G et al (2012) Effects of the association of potassium citrate and agropyrum repens in renal stone treatment: results of a prospective randomized comparison with potassium citrate. Arch Ital Urol Androl 84:61–67

    PubMed  Google Scholar 

  103. Monti E, Trinchieri A, Magri V, Cleves A, Perletti G (2016) Herbal medicines for urinary stone treatment. A systematic review. Arch Ital Urol Androl 88:38–46

    CAS  PubMed  Google Scholar 

  104. Patankar S, Dobhada S, Bhansali M et al (2008) A prospective, randomized, controlled study to evaluate the efficacy and tolerability of Ayurvedic formulation “varuna and banana stem” in the management of urinary stones. J Altern Complement Med 14:1287–1290

    PubMed  Google Scholar 

  105. Mohanty NK, Nayak RL, Patki PS (2010) Safety and efficacy of an Ayurvedic formulation Cystone in management of ureteric calculi: a prospective randomized placebo controlled study. Am J Pharmacol Toxicol 5:58–64

    Google Scholar 

  106. Shekar Kumaran MG, Patki PS (2011) Evaluation of an Ayurvedic formulation (Cystone), in urolithiasis: a double blind, placebo-controlled study. Eur J Integr Med 3:23–28

    Google Scholar 

  107. Upadhyay V, Malekar S, Deshpande S, Ahmad S, Shamsuddin (2011) Safety and efficacy of UNEX capsules in management of ureteric calculi: a prospective, randomised placebo-controlled study. Int J Green Pharm 5:346–349

    Google Scholar 

  108. Ceban A (2012) Efficacy of a fixed combination of Centaurii herba, Levistici radix and Rosmarini folium in urinary lithiasis. Results of an open randomised cohort study. Z Phytother 33:19–23

    Google Scholar 

  109. Faridi P, Seradj H, Mohammadi-Samani S, Vossoughi M, Mohagheghzadeh A, Roozbeh J (2014) Randomized and double-blinded clinical trial of the safety and calcium kidney stone dissolving efficacy of Lapis judaicus. J Ethnopharmacol 156:82–87

    CAS  PubMed  Google Scholar 

  110. Rathod RB, Amilkanthwar RH (2015) The effect of Kadalikshar in the management of Mutrashmari (Urolithiasis). Int J Res Ajurveda Pharm 6:315–319

    CAS  Google Scholar 

  111. Ardakani Movaghati MR, Yousefi M, Saghebi SA, Sadeghi Vazin M, Iraji A, Mosavat SH (2019) Efficacy of black seed (Nigella sativa L.) on kidney stone dissolution: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res 33:1404–1412

    CAS  PubMed  Google Scholar 

  112. Erickson SB, Vrtiska TJ, Lieske JC (2011) Effect of Cystone® on urinary composition and stone formation over a one year period. Phytomedicine 18:863–867

    CAS  PubMed  PubMed Central  Google Scholar 

  113. Erickson SB, Vrtiska TJ, Canzanello VJ, Lieske JC (2011) Cystone® for 1 year did not change urine chemistry or decrease stone burden in cystine stone formers. Urol Res 39:197–203

    PubMed  Google Scholar 

  114. Micali S, Sighinolfi MC, Celia A et al (2006) Can Phyllanthus niruri affect the efficacy of extracorporeal shock wave lithotripsy for renal stones? A randomized, prospective, long-term study. J Urol 176:1020–1022

    CAS  PubMed  Google Scholar 

  115. Peng Y, Hu XH, Li X, Zhou GP (2010) Quantong recipe integrated with ureteroscopic laser lithotripsy for ureteral calculi. Zhong Xi Yi Jie He Xue Bao 8:530–534

    CAS  PubMed  Google Scholar 

  116. Kobayashi M, Naya Y, Kino M, Awa Y, Nagata M, Suzuki H, Yamaguchi K, Nozumi K, Ichikawa T (2008) Low dose tamsulosin for stone expulsion after extracorporeal shock wave lithotripsy: efficacy in Japanese male patients with ureteral stone. Int J Urol 15:495–498

    CAS  PubMed  Google Scholar 

  117. Takada M, Yano H, Kanbara N, Kurita T, Kohri K, Kato Y, Iguchi M (1997) Effect of Chorei-to on spontaneous discharge of urinary stones after extracorporeal shock wave lithotripsy (ESWL). Hinyokika Kiyo 43:311–314

    CAS  PubMed  Google Scholar 

  118. Xiang W, Guo YL, Zhang JY, Zheng T, Zhang CH (2018) Curative effects of Ningmitai capsules on the residual fragments and postoperative complications following lithotripsy treatment of upper urinary calculi. Zhonghua Wai Ke Za Zhi 56:776–780

    CAS  PubMed  Google Scholar 

  119. Trinchieri A, Croppi E, Simonelli G, Sciorio C, Montanari E (2019) Anthropometric variables, physical activity and dietary intakes of patients with uric acid nephrolithiasis. Urolithiasis. https://doi.org/10.1007/s00240-019-01138-w(Epub ahead of print)

    Article  PubMed  Google Scholar 

  120. Chae JY, Kim JW, Kim JW, Yoon CY, Park HS, du Moon G, Oh MM (2013) Increased fluid intake and adequate dietary modification may be enough for the successful treatment of uric acid stone. Urolithiasis 41:179–182

    PubMed  Google Scholar 

  121. Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, Rutks IR et al (2013) Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Ann Intern Med 158:535–543

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. U-Merge Ltd. (Urology for Emerging Countries), London, UK

    Renato Nardi Pedro, Asad Ullah Aslam, Jibril Oyekunle Bello, Kamran Hassan Bhatti, Joseph Philipraj, Idrissa Sissoko, Alberto Trinchieri & Noor Buchholz

  2. Division of Urology, Faculdade de Medicina São Leopoldo Mandic de Campinas, Sao Paulo, Brazil

    Renato Nardi Pedro & Giovanna Souza Vasconcellos

  3. Department of Urology, Letterkenny University Hospital, Saolta Healthcare Group, Donegal, Ireland

    Asad Ullah Aslam

  4. Department of Surgery, University of Ilorin Teaching Hospital, Ilorin, Nigeria

    Jibril Oyekunle Bello

  5. Urology Department, Hamad Medical Corporation, Doha, Qatar

    Kamran Hassan Bhatti

  6. Department of Urology, Kasturba Medical College, Manipal, Karnataka, India

    Joseph Philipraj

  7. Urology, Faculty of Medicine and Odontostomatology, University of Sciences, Techniques and Technologies, Bamako, Mali

    Idrissa Sissoko

  8. Sobeh’s Vascular and Medical Center, U-Merge Ltd, Building 73, 3rd floor, Dubai Health Care City, Dubai, United Arab Emirates

    Noor Buchholz

Authors
  1. Renato Nardi Pedro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Asad Ullah Aslam
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jibril Oyekunle Bello
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kamran Hassan Bhatti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Joseph Philipraj
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Idrissa Sissoko
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Giovanna Souza Vasconcellos
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Alberto Trinchieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Noor Buchholz
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AUA, JOB, KHB, JP and IS searched the literature and wrote individual chapters of this manuscript. RNP, GSV and AT combined the chapters, streamlined and edited the first version of the manuscript. NB developed the concept, supervised and coordinated the project, edited and amended the final version.

Corresponding author

Correspondence to Noor Buchholz.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest in this publication.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pedro, R.N., Aslam, A.U., Bello, J.O. et al. Nutrients, vitamins, probiotics and herbal products: an update of their role in urolithogenesis. Urolithiasis 48, 285–301 (2020). https://doi.org/10.1007/s00240-020-01182-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00240-020-01182-x

Keywords

Search

Navigation